ARTICLE | Company News
Medivir, Daewoong Pharmaceutical, Hainan Noken Pharmaceutical Industry deal
March 22, 2010 7:00 AM UTC
Daewoong assumed exclusive rights to develop and commercialize Medivir's MIV-210 (lagociclovir valactate) in South Korea, Japan and China from Hainan. Medivir retains rights elsewhere. The nucleoside ...